CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −5,151 | $3.51 | $18K | 109,246 |
| 2021-03-31 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −2,573 | $6.84 | $18K | 114,397 |
| 2021-02-22 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +27,675 | 116,970 | ||
| 2021-02-22 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +64,575 | 64,575 | ||
| 2020-12-31 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −1,541 | $1.58 | $2K | 357,181 |
| 2020-11-30 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +7,838 | $1.45 | $11K | 358,722 |
| 2020-09-30 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −1,541 | $1.66 | $3K | 350,884 |
| 2020-06-30 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −1,541 | $1.73 | $3K | 352,425 |
| 2020-05-06 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +150,000 | 353,967 | ||
| 2020-05-06 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2020-04-06 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −908 | $1.40 | $1K | 203,967 |
| 2020-04-03 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +46,394 | 113,445 | ||
| 2020-04-03 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +91,430 | 204,875 | ||
| 2020-03-31 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −525 | $2.68 | $1K | 67,051 |
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +20,896 | 20,896 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +46,680 | 67,576 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +59,240 | 59,240 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +57,086 | 57,086 |
Page 1 of 1 · 18 trades